Skin Cancer section

Skin Cancer News & Features

Users Support Indoor Tanning Device Age Restrictions, Stronger Health Warnings, But Not Total Ban

Users Support Indoor Tanning Device Age Restrictions, Stronger Health Warnings, But Not Total Ban

Three-quarters of young adult women who visit indoor tanning salons support stronger restrictions on their use.

Study Supports Use of PD-1 Inhibitors in Acral, Mucosal Melanomas

Response rates with PD-1 inhibitors in patients with acral and mucosal melanomas were similar to previously reported rates in patients with cutaneous melanoma.

Some Gene Variants Increase the Risk for Melanoma in People With Red Hair, Freckling

Some Gene Variants Increase the Risk for Melanoma in People With Red Hair, Freckling

Variants of the MC1R gene, associated with red hair, pale skin, and freckles, increases the number of genetic mutations related to skin cancer and the level of other gene mutations, further increasing the risk for skin cancer.

Data Confirm Benefit of Cobimetinib and Vemurafenib in Melanoma

Cobimetinib in combination with vemurafenib as a standard first-line approach improves survival in patients with BRAF V600 mutation-positive melanoma, updated results of the coBRIM study.

USPSTF: Evidence Lacking to Recommend Full-body Skin Cancer Screens

USPSTF: Evidence Lacking to Recommend Full-body Skin Cancer Screens

New report doesn't change Task Force's prior statement on skin cancer screening issued in 2009

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs